RxDoctor Payments Data

Thuy Nacion, NP

Nurse Practitioner · Los Angeles, CANPI 1437423506

Payments from drug & device makers

$2,077in general payments, 2019–2025

Across 114 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacyclics LLC, An Abbvie Company$339
  • AbbVie$336
  • AstraZeneca$185
  • Bayer$151
  • Merck$113
  • Amgen$93
  • plus $861 from 26 others

What the payments were for

  • Food & beverage$2,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,077 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$4,887
Medicare patients
32
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib36$556,728
VerzenioAbemaciclib43$432,692
PomalystPomalidomide14$313,371
TagrissoOsimertinib Mesylate12$201,931
BrukinsaZanubrutinib13$195,236
IbrancePalbociclib12$194,343
EliquisApixaban34$42,408
XareltoRivaroxaban40$36,796
Letrozole38$1,008
Mirtazapine12$498
Lactulose46$377
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine18$336
Hydroxyurea20$308
Anastrozole13$305
Warfarin Sodium22$185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Pharmacyclics LLC, An Abbvie CompanyImbruvica$339$556,72836 claims
Lilly USA, LLCVerzenio$31$432,69243 claims
AstraZenecaTagrisso$185$201,93112 claims
Beigene USA, Inc.Brukinsa$41$195,23613 claims
Johnson & JohnsonXarelto$72$36,79640 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →